Discontinuation report GLYXAMBI
| Report ID | 139877 |
| Drug Identification Number | 02459760 |
| Brand name | GLYXAMBI |
| Common or Proper name | GLYXAMBI 25/5MG 3X10S |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LINAGLIPTIN EMPAGLIFLOZIN |
| Strength(s) | 5MG 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 3X10 BLISTER PACK |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-12-15 |
| Actual discontinuation date | 2021-12-09 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Inventory depleted |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2021-12-10 | English | Compare |
| v14 | 2021-12-09 | French | Compare |
| v13 | 2021-12-09 | English | Compare |
| v12 | 2021-11-11 | French | Compare |
| v11 | 2021-11-11 | English | Compare |
| v10 | 2021-10-29 | French | Compare |
| v9 | 2021-10-29 | English | Compare |
| v8 | 2021-10-07 | French | Compare |
| v7 | 2021-10-07 | English | Compare |
| v6 | 2021-09-17 | French | Compare |
| v5 | 2021-09-17 | English | Compare |
| v4 | 2021-08-19 | French | Compare |
| v3 | 2021-08-19 | English | Compare |
| v2 | 2021-05-25 | French | Compare |
| v1 | 2021-05-25 | English | Compare |
Showing 1 to 15 of 15